SCHEMBL24496004

SCHEMBL24496004

C=C(C)c1ccnc(-c2cc(S(=O)(=O)N(C)Cc3ccc(OC)cc3)ccc2Nc2ccc(C(F)(F)F)cn2)c1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ BMP1 P13497 2/20 0.39
▸ CCR6 P51684 1/20 0.37
▸ MMP1 P03956 3/20 0.36
▸ MMP9 P14780 3/20 0.36
▸ MMP13 P45452 3/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ MAPT P10636 2/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ MDM2 Q00987 1/20 0.35
▸ VNN1 O95497 1/20 0.35
▸ ADAM17 P78536 1/20 0.35
▸ CCR9 P51686 1/20 0.34
▸ SLC2A1 P11166 1/20 0.34
▸ DAGLA Q9Y4D2 2/20 0.34
▸ NAMPT P43490 1/20 0.34
▸ ABHD6 Q9BV23 1/20 0.34
▸ KDM4E B2RXH2 2/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29648296 0.91 BMP1 (0.39) BMP1CCR6MMP1MMP9MMP13
SCHEMBL24496262 0.91 BMP1 (0.39) BMP1CCR6MMP1MMP9MMP13
SCHEMBL29438883 0.86 MMP1 (0.40) BMP1CCR6MMP1MMP9MMP13
SCHEMBL22718255 0.86 MMP1 (0.40) BMP1CCR6MMP1MMP9MMP13
SCHEMBL24496140 0.86 CCR6 (0.38) BMP1CCR6MMP1MMP9MMP13
SCHEMBL29438915 0.83 TEAD1 (0.49) BMP1CCR6MMP1MMP9MMP13
SCHEMBL22718251 0.83 TEAD1 (0.49) BMP1CCR6MMP1MMP9MMP13
SCHEMBL29438917 0.83 TEAD1 (0.49) BMP1CCR6MMP1MMP9MMP13
SCHEMBL24880098 0.82 BMP1 (0.39) BMP1CCR6MMP1MMP9MMP13
SCHEMBL24496050 0.81 TEAD1 (0.39) BMP1CCR6MMP1MMP9MMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4281073-A1 COMBINATION OF A 3-(IMIDAZOL-4-YL)-4-(AMINO)-BENZENESULFONAMIDE TEAD INHIBITOR WITH AN EGFR INHIBITOR AND/OR MEK INHIBITOR FOR USE IN THE TREATMENT OF LUNG CANCER Ikena Oncology, Inc. (US) 2023-11-29 — — EP disclosed
WO-2022159986-A1 COMBINATION OF A 3-(IMIDAZOL-4-YL)-4-(AMINO)-BENZENESULFONAMIDE TEAD INHIBITOR WITH AN EGFR INHIBITOR AND/OR MEK INHIBITOR FOR USE IN THE TREATMENT OF LUNG CANCER Ikena Oncology, Inc. (US) 2022-07-28 — — WO disclosed
WO-2022120353-A1 TEAD INHIBITORS AND USES THEREOF Ikena Oncology, Inc. (US) 2022-06-09 — — WO disclosed
WO-2022120353-A1 TEAD INHIBITORS AND USES THEREOF Ikena Oncology, Inc. (US) 2022-06-09 — — WO disclosed
WO-2022120355-A1 TEAD DEGRADERS AND USES THEREOF Ikena Oncology, Inc. (US) 2022-06-09 — — WO disclosed
WO-2022120355-A1 TEAD DEGRADERS AND USES THEREOF Ikena Oncology, Inc. (US) 2022-06-09 — — WO disclosed
Send feedback